Table 2.
Metabolic parameters
| Parameter | Mean (95% CI) | Median (range) |
|---|---|---|
| Albumin (g/100 mL)a | 3.49 (3.33–3.64) | 3.60 (2.40–4.40) |
| BMI (kg/m2) | 24.56 (23.12–26.00) | 23.82 (14.88–39.35) |
| SMI (cm2/m2) | 42.43 (39.65–45.20) | 41.31 (28.12–63.76) |
| FFMI (kg/m2) | 14.91 (14.09–15.73) | 14.55 (10.65–21.11) |
| FMI (kg/m2) | 8.49 (7.74–9.23) | 7.80 (5.02–15.78) |
| Weight change (%)b | −4.48 (−7.28–−1.69) | −3.2 (−30.30–12.30) |
Notes: aAlbumin - missing values of two patients. bA positive weight change indicates an increase in weight from initial diagnosis of advanced disease to start of nivolumab immunotherapy.
Abbreviation: CI, confidence interval.